Dolutegravir is recommended by the World Health Organization (WHO) for infants, children and adults and is the preferred HIV ...

Cuts to sexual health clinics could make eliminating new HIV cases in England by 2030 “impossible”, politicians have warned.

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

GSK posted higher profit as sales for its specialty treatments including HIV, cancer and asthma beat expectations, offsetting lower vaccine sales on weak demand in the U.S.

GSK posted higher profit as sales for its specialty treatments for HIV, cancer and asthma beat expectations, offsetting lower ...

An HIV patient in Laredo is sharing his advice with others living with the disease to raise awareness and highlight available ...

Williams dedicated his life to reaching others and empowering his queer community to rise above fear. And in a powerful reminder of his lasting impact, National Black AIDS Awareness Day is observed ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV medicines.

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...

Improving adherence to antiretroviral therapy (ART) in youth living with HIV requires interventions that target both family ...